Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023.
- Second-quarter revenue came in at $1.18 billion, up 1% from Q2 2022; a 3% increase on a constant currency basis
- Net loss per share was $1.48 in Q2, compared to a loss per share of $3.40 in the year-ago quarter
- On an adjusted basis, it was earnings of $0.32 per share for Q2 2023, compared to $0.57 per share last year
- The company expects fiscal year 2023 consolidated revenue growth of approximately 1%
- It is looking for a loss in the range of $2.08 per share to $1.93 per share for fiscal 2023
- Full-year adjusted earnings per share is expected to be in the range of $0.75 to $0.90
Most Popular
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings
A look at how Disney’s (DIS) entertainment business performed in Q2 2024
Shares of the Walt Disney Company (NYSE: DIS) stayed green on Wednesday. The stock has gained 16% year-to-date. The company recorded revenue and earnings growth for the second quarter of
Uber Technologies reports wider loss for Q1 2024; revenue up 15%
Uber Technologies, Inc. (NYSE: UBER) on Wednesday reported a wider net loss for the first quarter of 2024. Revenues of the ride-sharing giant increased 15% during the three months. Net